Home-based Respiratory Training on Swallowing in Stroke

NCT ID: NCT06312319

Last Updated: 2024-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-20

Study Completion Date

2024-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the effects of a home-based respiratory muscle training on swallowing function in patients with chronic stroke. The patients will be included in a experimental or a control group. The patients in the experimental group will receive a home-based respiratory training using respiratory devices added to standard treatment, while the participants in the control group will only receive the standard treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to evaluate the effects of a home-based respiratory muscle training on swallowing function in patients with chronic stroke. The patients will be included in a experimental or a control group. The patients in the experimental group will receive home-based respiratory training using respiratory devices added to standard treatment, while the participants in the control group will only receive the standard treatment. The swallowing function will be assessed using specific tools and questionnaires. Secondary outcomes will evaluate the respiratory function. The intervention will have a duration of 6 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Respiratory training added to orofacial exercises

Home-based respiratory training of the inspiratory and expiratory muscles using a device added to standard treatment including orofacial exercises.

Group Type EXPERIMENTAL

Respiratory training

Intervention Type DEVICE

Respiratory training using the EMST 150 device to increase inspiratory and expiratory muscle strength.

Orofacial exercises

Intervention Type OTHER

The exercises will include activities to improve orofacial structures such as mobility, strength and coordination.

Orofacial exercises

Standard treatment including orofacial exercises.

Group Type ACTIVE_COMPARATOR

Orofacial exercises

Intervention Type OTHER

The exercises will include activities to improve orofacial structures such as mobility, strength and coordination.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Respiratory training

Respiratory training using the EMST 150 device to increase inspiratory and expiratory muscle strength.

Intervention Type DEVICE

Orofacial exercises

The exercises will include activities to improve orofacial structures such as mobility, strength and coordination.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of stroke
* 18 years of age or more

Exclusion Criteria

* Cognitive impairment or aphasia that prevents the understanding of instructions.
* Tracheostomy.
* Presence of cancer.
* Patients who present another disease of the central nervous system
* Absence of neuromotor competence to carry out the respiratory function tests.
* Central apnea.
* Hypoventilation-obesity syndrome.
* Severe cardiorespiratory impairment (hemodynamic instability, pulmonary embolism, recent pneumonothorax, acute hemoptysis, active respiratory infections, recent myocardial infarction, unstable angina, pulmonary hypertension, uncontrolled asthma, or severe chronic obstructive pulmonary disease).
* Patients with recent otorhinolaryngological, abdominal, or thoracic surgery.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Granada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Irene Cabrera Martos

Profesor titular de Universidad

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Irene Cabrera Martos

Role: PRINCIPAL_INVESTIGATOR

UGR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Health Sciences

Granada, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Irene Cabrera Martos

Role: CONTACT

958248763

Irene Cabrera Martos

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Irene Cabrera Martos

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DF0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.